Abstract-Artemisinin and its derivatives are a promising new class of antimalarial agents containing an endoperoxide bridge. ["'C]Artemisinin alkylated various proteins in uitro. Between 5 and 18% of added drug bound to hemoproteins such as catalase, cytochrome c, and hemoglobin. However, it did not react with heme-free globin. For catalase and hemoglobin, most of the drug reacted with the protein moiety rather than the heme. Artemisinin bound to human serum albumin (HSA) more efficiently at pH 8.6 than 7.4, more efficiently in Dulbecco's PBS than in Tris-HCl buffer, and better when HSA had been made fatty acid-free. Dihydroartemisinin also bound to HSA, whereas deoxyartemisinin, an inactive derivative, did not. There was no binding between DNA and artemisinin. These data provide insight into the mechanism of the reaction between artemisinin and proteins.
Reed Army Institute of Research, Washington, DC. Dihydroartemisinin was a gift from Dr. H. Z. Pan, Institute ofBasicMedicalSciences,Beijing, China. Dulbecco's PBS was from Gibco BRL (Grand Island, NY) . Blood (Type A+) was purchased from the Interstate Blood Bank, Memphis, TN. Red blood cell lysate was prepared by mixing fresh blood cells with hypotonic buffer (10mM NaH2P04, 6.6mM Na2HP04, pH 7.4) [16] and then removing membranes by centrifuging at 11,525g on a microcentrifuge. Bradford protein reagent was purchased from Bio-Rad Laboratories (Richmond, CA). Artemisinin, bovine liver catalase, horse heart cytochrome c, HSA (globin-free), HSA (fatty acidfree, globin-free), methemoglobin, salmon testes DNA, and all other chemicals were purchased from the Sigma Chemical Co. (St. Louis, MO).
Reactions between artemisinin and proteins.
Reaction mixtures contained 1 mg/mL of the appropriate protein and 11 nCi/mL [14C]artemisinin in PBS (pH 7.4). Control reaction mixtures lacking protein were carried out in tandem under identical conditions. After 24 hr incubations at 37", a 500 PL aliquot from each mixture was applied to an NAP-5 size-exclusion column (Pharmacia, Uppsala, Sweden) preequilibrated in PBS, pH 7.4. The protein content of the eluate was determined by the method of Bradford [17] . High and low molecular weight material separated with the initial 0.9 mL eluate and the subsequent 3 mL eluate, respectively. A 100 PL 570 YING-ZI YANG, B. LITI-LE and S. R. MESHNICK 
Extraction of heme and heme adducts. [14C]-
Artemisinin-labeled erythrocyte lysate and catalase were both prepared as described above. The heme and protein moieties were separated by a modification of the method of Fuhrhop and Smith [lS] . Aliquots of 5OOpL were mixed with 10mL ethyl acetate, followed by SOOpL of glacial acetic acid/saturated Na2S04 (4: 1) in a glass tube. The tubes were inverted, an equal volume of 1% Na2S04 was added, and the mixtures were shaken briefly by hand. The tubes were allowed to sit until the mixtures separated into two layers. The organic layer contained more than 99% of the total heme, and no detectable heme was left in the aqueous phase as determined by the pyridine hemochromogen assay [18] . Both layers were recovered and counted separately as described above.
Buffer and pH eflectv on binding of artemtsinin and der~oati~es to albumin. HSA (1 mg) was dissolved in 1 mL of each of the following buffers: PBS (pH 7.4); PBS (pH 8.6); Tris (150 mM, pH 7.4); and Tris (150 mM, pH 8.6). Unlabeled artemisinin, dihydroartemisinin, or deoxyartemisinin was added to a final concentration of 1 mM from a 10 mM ethanolic stock solution. Controls lacking protein were prepared simult~eously.
Mixtures were incubated at 37" for 24 hr. Proteins were separated from free drug by four spins through Centriconmicroconcentrators (Amicon Division, W.R. Grace & Co., Beverly, MA). Concentrates were recovered and diluted to a protein concentration of 1 mg/mL. Spectra were obtained on a Hewlett Packard model 8452 Spectrophotometer.
RESULTS
[14C]Artemisinin bound covalently to various proteins (Table 1 ). Up to 18% of the total label eluted in the high molecular weight fraction that contained >QQ% of the total protein. In the absence of protein, < 1% of the added radioactivity eluted in this fraction. All of the hemoproteins tested bound artemisinin. Catalase and cytochrome c bound 8 and 5%, respectively, of added drug. Methemoglobin bound the most drug, 18% of the total. Fresh blood lysates, which consist predominantly of reduced hemoglobin, bound only 8% of total radioacti~ty. In contrast, heme-free globin bound negligible amounts of drug (1.6%). HSA only bound a very small percentage (2.4%) of radioactive artemisinin. However, fatty acid-free HSA bound substantially more drug (ll%), suggesting that artemisinin can bind and react in the hydrophobic pocket of the protein. There was no binding to DNA (less than 1%).
To determine whether the hemoprotein-bound [14C]artemisinin is associated with protein or heme, the protein and heme moieties were separated by extraction (Table 2 ). For both hemoglobin and catalase, only approximately 20% of the proteinassociated radioacti~ty was recovered in the ethyl acetate layer, which contained >QQ% of the original heme content.
When artemisinin-labeled HSA (which does not contain heme) was used as a control for this extraction, 8% of total radioactivity was detected in the ethyl acetate layer. These data suggest that when hemoglobin and catalase are alkylated, most of the drug becomes attached to the protein moiety.
The reaction between artemisinin and HSA was pH and buffer dependent (Fig. 1) . Artemisininbound HSA had a distinct absorption peak at 306 nm. The area of the peak reflected the relative amount of alkylated protein, since it increased with reaction time (data not shown). Reactions at pH 7.4 in either PBS or Tris buffer were less efficient than in the corresponding pH 8.6 buffer. The reaction of artemisinin with HSA, therefore, is favored at high pH. Reactions in PBS at both pH 7.4 and 8.6 were more efficient than in Tris at the same pH levels.
To better understand the binding of artemisinin and Tris, pH8.6 (------).
to HSA, two derivatives of artemisinin, dihydroartemisinin and deoxyartemisinin, were also used to study binding (Fig. 2) . Artemisinin appeared to be more reactive than either derivative. However, there was a definite reaction between HSA and dihydroartemisinin, an active artemisinin derivative. The endoperoxide bridge appears to be necessary for the reaction since deoxyartemisinin, an inactive derivative. did not react with HSA.
DISCUSSION
Artemisinin has been shown previously to form covalent adducts with HSA [12] , red cell membrane proteins [13] , and heme [14, 15] . Heme and iron catalyse the decomposition of artemisinin into reactive free radicals [lo] and electrophiles [ll], which could act as alkylating agents. This could explain the selective toxicity of artemisinin derivatives to malaria, since malaria parasites have high intracellular stores of heme. These reactions could also explain some of the adverse effects of the drug [ 191. However, both iron-dependent and independent reactions between artemisinin and HSA have been observed [12] . Thus, further work was needed to define the role of heme and iron as catalysts for protein alkylation.
In the present study, hemoproteins, such as hemoglobin, catalase, and cytochrome c, were found to react quite well with artemisinin. Most of the hemoglobin-or catalase-bound radioactivity was associated with the protein moiety rather than the heme. Yet heme-free globin did not react with artemisinin. These data suggest that in hemoproteins heme catalyses the alkylation of the protein moiety. Wavelength (nml Fig. 2 . Absorption spectra of HSA after reaction with artemisinin (-----), dihydroartemisinin (------), deoxyartemisinin (--) , and in the absence of drug (-) .
HSA was incubated with 1 mM concentrations of the drugs for 24 hr in Tris buffer (pH 8.6 ) and then separated from free drug as described in Materials and Methods.
Many alkylating agents target DNA [20] . Thus, it was necessary to determine whether artemisinin might act in this manner. However, the lack of reactivity between artemisinin and DNA suggests that DNA alkylation is not an important part of the mode of action of the drug.
HSA binds noncovalently to many drugs and small molecules, including fatty acids [21, 22] . The binding of one compound is often influenced by the binding of a second compound, either by direct competition or by an allosteric interaction [22] . For example, fatty acids have been shown to inhibit the binding of dansylsarcosine by direct competition [23] and of diazepam allosterically [24, 25] . The fact that more HSA is alkylated by artemisinin when it is fatty acidfree suggests that the drug may be binding at the fatty acid binding site, or a site that is allosterically regulated by fatty acid binding.
The reaction between artemisinin and HSA occurred faster at higher pH. There are two possible explanations for this. First, artemisinin may decompose spontaneously at alkaline pH into a diketone that might be reactive with amino acids [26] . A second explanation is that protein amino groups become unprotonated at higher pH levels and are, therefore, better nucleophiles. Nucleophilic amines may also explain why the reaction proceeds better in PBS than in Tris buffer at identical pH, because the amino group in Tris may compete for the reaction with artemisinin.
Dihydroartemisinin is an important analog of artemisinin. It is the principle active metabolite of Alkylation of proteins by artemisinin 513 the three most important artemisinin derivatives in clinical use-artemether, arteether, and artesunate [4] . We have demonstrated previously that both artemisinin and dihydroartemisinin form covalent adducts with HSA [12] . Here we show that artemisinin forms a chromophore with HSA at a faster rate than dihydroartemisinin.
This suggests either that the presence of a lactone moiety increases the reaction efficiency or that the dihydroartemisinin-HSA chromophore has a different structure than the artemisinin-HSA chromophore.
In contrast, no chromophore forms when deoxyartemisinin is incubated with HSA, suggesting that there is no reaction. This implies that the endoperoxide bridge, which is necessary for antimalarial activity, is necessary for protein alkylation.
